Products

What will AGI do for Bisantrene?

This classification denotes an anthraquinone compound with the molecular formula C22H22N8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 39C34M111K, chemically known as 9,10-anthracenedicarboxaldehyde, bis((4,5-dihydro-1h-imidazol-2-yl)hydrazone)- but generally known as bisantrene, which bears US NIH Compound Identifier 5351322. Bisantrene most often comes in base, dihydrochloride, and hydrochloride forms. European Medicines Agency schedules Bisantrene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05847MIG. The term BISANTRENE is an International Non-Proprietary Name. BISANTRENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bisantrene under HS 29332990 and SITC 51573. As of Q4 2014, BISANTRENE remains the US FDA Preferred Term for this commodity. Bisantrene bears US NLM identifiers UMLS ID C0053776 and NCI Concept Code C1019. SMILES: N1CCN=C1N/N=C/C1C2C(C(C3C1CCCC3)/C=N/NC1=NCCN1)CCCC2.

How AGI delivers it

Four ways AGI delivers for Bisantrene

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Bisantrene, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Bisantrene, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Bisantrene connects

measured by

  • Assay Puritymodel
  • Impurity Profilemodel
  • Residual Solventmodel